Literature DB >> 6346899

Renal nerves in the pathogenesis of hypertension in experimental animals and humans.

R E Katholi.   

Abstract

Efferent renal innervation is composed of postganglionic sympathetic fibers to the renal arterioles, juxtaglomerular apparatus, and renal tubules. Increased efferent renal sympathetic nerve activity results in increased renal vascular resistance, renin release, and sodium retention. These responses from enhanced renal sympathetic activity contribute to normal cardiovascular homeostasis but could also facilitate the development of hypertension by shifting the arterial pressure-renal sodium excretion curve to the right. Accordingly, interruption of the renal nerves should prevent the development of hypertension in animal models in which increased sympathetic nervous system activity has been implicated. Renal denervation delays the development of hypertension and results in greater sodium excretion in the Okamoto and New Zealand spontaneously hypertensive rat and in the DOCA-salt-treated rat, suggesting that these responses are due, at least in part, to loss of efferent renal nerve activity. Similar sympathetically mediated renal vasoconstriction has been implicated in the pathogenesis of early essential hypertension in man. Recent studies indicate that the kidney is a sensory organ with mechano-receptive and chemoreceptive afferent renal nerves involved in renorenal and cardiovascular regulation. Renal denervation in established one-kidney one-clip and two-kidney one-clip Goldblatt hypertension in the rat and chronic coarctation in the dog results in an attenuation of the hypertension. The depressor effect of renal denervation in these models is not due to change in renin activity or sodium excretion but is associated with decreased activity of the sympathetic nervous system. These findings suggest that the afferent renal nerves contribute to the pathogenesis of renovascular hypertension by enhancing the activity of the sympathetic nervous system. The role of the afferent renal nerves in renovascular hypertension in humans warrants further study.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6346899     DOI: 10.1152/ajprenal.1983.245.1.F1

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  30 in total

Review 1.  Renal afferents and hypertension.

Authors:  John Ciriello; Cleusa V R de Oliveira
Journal:  Curr Hypertens Rep       Date:  2002-04       Impact factor: 5.369

Review 2.  Renal autoregulation in health and disease.

Authors:  Mattias Carlström; Christopher S Wilcox; William J Arendshorst
Journal:  Physiol Rev       Date:  2015-04       Impact factor: 37.312

3.  Prostaglandin E2 inhibits and indomethacin enhances noradrenaline release in isolated kidneys of adult spontaneously hypertensive rats.

Authors:  L C Rump; K Wilde; P Schollmeyer
Journal:  Br J Clin Pharmacol       Date:  1990       Impact factor: 4.335

Review 4.  Resistant Hypertension and Renal Nerve Denervation.

Authors:  Matthew G Denker; Debbie L Cohen
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Oct-Dec

5.  Myocyte loss in early left ventricular hypertrophy of experimental renovascular hypertension.

Authors:  Moriz Buzello; Christoph Boehm; Stephan Orth; Bernhard Fischer; Heimo Ehmke; Eberhard Ritz; Gerhard Mall; Kerstin Amann
Journal:  Virchows Arch       Date:  2003-04-02       Impact factor: 4.064

Review 6.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

Review 7.  Catheter-based Renal Artery Denervation for Resistant Hypertension: Promise Unfulfilled or Unsettled?

Authors:  Matthew G Denker; Debbie L Cohen; Raymond R Townsend
Journal:  Curr Atheroscler Rep       Date:  2015-10       Impact factor: 5.113

8.  Effects of the novel dopamine DA2-receptor agonist carmoxirole (EMD 45609) on noradrenergic and purinergic neurotransmission in rat isolated kidney.

Authors:  L C Rump; K Wilde; C Bohmann; P Schollmeyer
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-03       Impact factor: 3.000

9.  The rat renal nerves during development.

Authors:  L Liu; L Barajas
Journal:  Anat Embryol (Berl)       Date:  1993-10

10.  Dopamine receptor modulation of noradrenaline release by carmoxirole in human cortical kidney slices.

Authors:  L C Rump; E Schwertfeger; U Schaible; M J Schuster; A Frankenschmidt; P Schollmeyer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.